Cognex Corp. (NASDAQ:CGNX) Director Bruce Robinson J sold 25,750 shares of the business’s stock in a transaction dated Friday, November 25th. The stock was sold at an average price of $60.95, for a total transaction of $1,569,462.50. Following the sale, the director now directly owns 16,875 shares of the company’s stock, valued at approximately $1,028,531.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Cognex Corp. (NASDAQ:CGNX) opened at 60.02 on Tuesday. The firm has a market capitalization of $5.14 billion, a price-to-earnings ratio of 39.88 and a beta of 1.32. Cognex Corp. has a 12-month low of $28.01 and a 12-month high of $61.50. The firm has a 50-day moving average of $54.54 and a 200 day moving average of $48.34.

Cognex Corp. (NASDAQ:CGNX) last announced its quarterly earnings data on Monday, October 31st. The company reported $0.61 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.48 by $0.13. Cognex Corp. had a net margin of 26.59% and a return on equity of 13.67%. The firm earned $147.95 million during the quarter, compared to analysts’ expectations of $50.93 million. During the same quarter last year, the business earned $1.19 earnings per share. The business’s revenue for the quarter was up 37.5% compared to the same quarter last year. On average, equities analysts predict that Cognex Corp. will post $1.57 EPS for the current year.

Insider Buying and Selling by Quarter for Cognex Corp. (NASDAQ:CGNX)

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 16th. Investors of record on Friday, December 2nd will be paid a $0.075 dividend. This represents a $0.30 annualized dividend and a dividend yield of 0.50%. The ex-dividend date is Wednesday, November 30th. Cognex Corp.’s dividend payout ratio (DPR) is 20.13%.

WARNING: “Cognex Corp. (CGNX) Director Bruce Robinson J Sells 25,750 Shares of Stock” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international copyright & trademark legislation. The correct version of this article can be accessed at https://www.thecerbatgem.com/2016/11/29/cognex-corp-cgnx-director-bruce-robinson-j-sells-25750-shares-of-stock.html.

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in shares of Cognex Corp. by 2.7% in the second quarter. Vanguard Group Inc. now owns 5,934,981 shares of the company’s stock valued at $255,797,000 after buying an additional 154,645 shares during the period. BlackRock Fund Advisors boosted its stake in shares of Cognex Corp. by 4.2% in the third quarter. BlackRock Fund Advisors now owns 3,147,606 shares of the company’s stock valued at $166,382,000 after buying an additional 126,659 shares during the period. Royce & Associates LP boosted its stake in shares of Cognex Corp. by 0.8% in the second quarter. Royce & Associates LP now owns 2,669,509 shares of the company’s stock valued at $115,056,000 after buying an additional 21,100 shares during the period. BlackRock Institutional Trust Company N.A. boosted its stake in shares of Cognex Corp. by 1.4% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 2,478,391 shares of the company’s stock valued at $131,008,000 after buying an additional 34,602 shares during the period. Finally, Joho Capital LLC boosted its stake in shares of Cognex Corp. by 9.7% in the third quarter. Joho Capital LLC now owns 1,690,138 shares of the company’s stock valued at $89,341,000 after buying an additional 149,589 shares during the period. Hedge funds and other institutional investors own 91.82% of the company’s stock.

CGNX has been the subject of a number of research reports. Stephens initiated coverage on shares of Cognex Corp. in a research note on Tuesday, October 25th. They set an “equal weight” rating and a $50.00 target price for the company. raised shares of Cognex Corp. from an “underperform” rating to an “outperform” rating in a research note on Monday, November 7th. Canaccord Genuity set a $49.00 price objective on shares of Cognex Corp. and gave the company a “hold” rating in a research note on Tuesday, September 20th. Zacks Investment Research cut shares of Cognex Corp. from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 19th. Finally, Needham & Company LLC upped their price objective on shares of Cognex Corp. from $55.00 to $61.00 and gave the company a “buy” rating in a research note on Tuesday, November 1st. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $49.11.

About Cognex Corp.

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

5 Day Chart for NASDAQ:CGNX

Receive News & Stock Ratings for Cognex Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Corp. and related stocks with our FREE daily email newsletter.